Barclays PLC Portfolio Holdings

Barclays PLC

  • $436 Billion
  • Q2 2025

Barclays PLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $436 Billion distributed in 12350 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $17.4B, Nvidia Corp with a value of $15.9B, Apple Inc. with a value of $9.34B, Amazon Com Inc with a value of $7.98B, and Tesla, Inc. with a value of $6.51B.

Examining the 13F form we can see an increase of $184B in the current position value, from $252B to 436B.

Barclays PLC is based out at London, X0

Below you can find more details about Barclays PLC portfolio as well as his latest detailed transactions.

Portfolio value $436 Billion
ETFs: $158 Billion
Technology: $99.7 Billion
Consumer Cyclical: $34.9 Billion
Financial Services: $33.3 Billion
Communication Services: $27 Billion
Industrials: $20.8 Billion
Healthcare: $20 Billion
Consumer Defensive: $11.9 Billion
Other: $21.9 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Cantor Equity Partners Ii In
-
$552,000 0.0% of portfolio
-
Q2 2025 New
$466M
$662,000 0.0% of portfolio
19,718
Q2 2025 Added 113.91%
$738M
$2.27 Million 0.0% of portfolio
57,741
Q2 2025 Added 23.57%
$616M
$545,000 0.0% of portfolio
24,717
Q2 2025 Reduced 83.89%
$879M
$1.79 Million 0.0% of portfolio
293,827
Q2 2025 Added 29.07%
$3.01B
$8.7 Million 0.0% of portfolio
491,645
Q2 2025 Added 343.71%
$150M
$1.3 Million 0.0% of portfolio
130,911
Q2 2025 Added 68.81%
$87.5M
$339,000 0.0% of portfolio
107,536
Q2 2025 Added 74.13%
$41.8M
$23,000 0.0% of portfolio
13,914
Q2 2025 Reduced 73.96%
$749M
$3.66 Million 0.0% of portfolio
186,985
Q2 2025 Added 94.78%
$3.33B
$12 Million 0.0% of portfolio
391,348
Q2 2025 Added 35.76%
Cargo Therapeutics Inc
-
$261,000 0.0% of portfolio
-
Q2 2025 Added 43.14%
$3.77B
$13.4 Million 0.0% of portfolio
399,086
Q2 2025 Reduced 3.15%
$111M
$27,000 0.0% of portfolio
21,688
Q2 2025 Reduced 79.23%
Caris Life Sciences Inc
-
$267,000 0.0% of portfolio
-
Q2 2025 New
Carisma Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 99.98%
$41.4M
$97,000 0.0% of portfolio
130,818
Q3 2024 Reduced 2.3%
$627M
$1.38 Million 0.0% of portfolio
30,207
Q2 2025 Added 107.32%
$914M
$1.41 Million 0.0% of portfolio
119,010
Q2 2025 Added 39.28%
$476M
$661,000 0.0% of portfolio
38,136
Q2 2025 Added 66.57%
$1.2B
$2.44 Million 0.0% of portfolio
80,917
Q2 2025 Added 227.52%
Cartesian Therapeutics Inc
-
$318,000 0.0% of portfolio
-
Q2 2025 Added 113.48%
$4.43B
$16.3 Million 0.0% of portfolio
141,518
Q2 2025 Reduced 44.14%
$20.7B
$9.93 Million 0.0% of portfolio
19,459
Q2 2025 Added 15.63%
$582M
$1.03 Million 0.0% of portfolio
23,676
Q2 2025 Added 37.1%
$83.4M
$5,000 0.0% of portfolio
2,734
Q2 2025 Reduced 93.8%
$569M
$2.24 Million 0.0% of portfolio
109,743
Q2 2025 Added 156.32%
$2.03B
$8 Million 0.0% of portfolio
368,836
Q2 2025 Added 86.2%
$3.57B
$6.97 Million 0.0% of portfolio
153,038
Q2 2025 Added 43.36%
$89.7M
$10,000 0.0% of portfolio
3,712
Q2 2025 Reduced 7.71%
Cava Group Inc
-
$3.98 Million 0.0% of portfolio
-
Q2 2025 Added 0.91%
$4.9B
$9.4 Million 0.0% of portfolio
21,639
Q2 2025 Added 32.34%
$170M
$452,000 0.0% of portfolio
15,865
Q2 2025 Added 113.53%
$2.92B
$7.34 Million 0.0% of portfolio
102,278
Q2 2025 Added 66.27%
$1.01B
$1.08 Million 0.0% of portfolio
42,680
Q2 2025 Added 21.77%
$6.02B
$1.11 Million 0.0% of portfolio
117,629
Q2 2025 Reduced 49.25%
$0
$1.62 Million 0.0% of portfolio
57,147
Q2 2025 Added 50.41%
$4.89B
$8.75 Million 0.0% of portfolio
158,167
Q2 2025 Reduced 29.19%
$816M
$1.04 Million 0.0% of portfolio
78,076
Q2 2025 Added 120.7%
Celestica Inc
-
$5.08 Million 0.0% of portfolio
-
Q2 2025 Added 5.92%
$1.15B
$5.35 Million 0.0% of portfolio
262,725
Q2 2025 Added 125.39%
$3.31B
$2.24 Million 0.0% of portfolio
140,037
Q2 2025 Reduced 9.08%
$13.7B
$890,000 0.0% of portfolio
128,481
Q2 2025 Added 1,028.61%
Cenovus Energy Inc
-
$5,000 0.0% of portfolio
-
Q2 2025 Reduced 7.02%
$33.7B
$445,000 0.0% of portfolio
32,804
Q2 2025 Added 695.63%
Centerpoint Energy Inc
-
$5.04 Million 0.0% of portfolio
-
Q2 2025 Added 282.13%
$2.02B
$2.5 Million 0.0% of portfolio
347,300
Q2 2025 Reduced 7.56%
$883M
$3.5 Million 0.0% of portfolio
58,117
Q2 2025 Added 29.18%
$2.08B
$99,000 0.0% of portfolio
7,519
Q2 2025 Reduced 80.3%

Summary

  • Portfolio
  • No. of Stocks 12,350
  • Current Value $436 Billion
  • Prior Value $252 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR/A
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email